Mi-mAbs is  an innovative integrated immunotechnology center designed to accelerate the development of new immunotherapy antibodies against cancer and inflammatory diseases. 
Open to the best targets of academic and industrial research, MI-mAbs determines their expression profile, generates antibodies and validates them. A multi-disciplinary team, involving experts in hybridoma, in molecular biology, biochemistry, immunochemistry , anatomopathology and in vitro / in vivo immunopharmacology has an objective to be the 1st integrated platform that generates and validates therapeutic antibodies. MI-mAbs contracts with research institutions, public technology transfer offices, or biotech companies

There are two parts to the Festival of Biologics: the five world-class international conferences covering Antibodies, Immunotherapy, BioSimilars, Clinical Trials, and High Potency APIs; and an exhibition featuring the most exciting technology and solutions for pharma and biotech. There is a registration fee to attend the conferences. To visit the exhibition is free.


Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October

Sign Up for Event Updates